Hadjigol, Sara <br/><br/>
Lipopolysaccharide induces steroid-resistant exacerbations in a mouse model of allergic airway disease collectively through IL-13 and pulmonary macrophage activation.  [electronic resource] 

 -  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology  01 2020 
 - 82-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2222 
<br/><br/><label>Standard No.: </label>10.1111/cea.13505  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Airway Resistance--drug effects<br/>Animals<br/>Asthma--immunology<br/>Bacterial Infections<br/>Bronchoalveolar Lavage Fluid--cytology<br/>Chemokine CCL2<br/>Cytokines--drug effects<br/>Dexamethasone--pharmacology<br/>Disease Models, Animal<br/>Disease Progression<br/>Drug Resistance<br/>Glucocorticoids--pharmacology<br/>Interferon-gamma--drug effects<br/>Interleukin-13--immunology<br/>Interleukins--immunology<br/>Lipopolysaccharides--pharmacology<br/>Macrophage Activation--drug effects<br/>Macrophages, Alveolar--drug effects<br/>Mice<br/>Mucin 5AC--drug effects<br/>Ovalbumin<br/>Respiratory Hypersensitivity--immunology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Necrosis Factor-alpha--drug effects